期刊文献+

非p53依赖通路c-myc基因对p14^ARF基因的调控及细胞凋亡的诱导 被引量:1

Regulation of p14ARF expression and induction of cell apoptosis with c-myc in a p53-independentpathway
原文传递
导出
摘要 目的了解非p53依赖通路突变型与野生型c-myc基因对p14^ARF基因表达调控及细胞凋亡的诱导功能。方法分别用携带突变型与野生型c-myc基因的慢病毒载体感染p53缺失型乳腺癌HCC1937细胞并得到二者过表达的稳定细胞株,未感染组及感染不携带c-myc基因的慢病毒细胞作空白对照和感染对照,采用反转录(RT)-PCR、Western印迹分别检测突变型与野生型c-myc及p14^ARF基因mRNA和蛋白表达,采用MTT、原位末端标记(TUNEL)检测突变型与野生型c-myc基因过表达乳腺癌HCC1937细胞增殖与凋亡情况。结果RT-PCR和Western印迹均显示突变型组与野生型组c-myc基因mRNA和蛋白过表达,突变型与野生型组c-myc蛋白[c-myc/β-肌动蛋白(actin)]表达量分别为0.560±0.010、0.651±0.010,与两对照组相比差异具有统计学意义(P〈0.05);野生型组p14^ARF蛋白(p14^ARF/β-actin)表达量为0.382±0.013,与两对照组相比差异均有统计学意义(均P〈0.05);突变型组p14^ARF蛋白(p14^ARF/β-actin)表达量为0.154±0.011,与两对照组相比,差异均无统计学意义(均P〉0.05)。突变型组细胞增殖活性显著高于野生型组(P〈0.05),突变型组与两对照组细胞凋亡率比较差异均无统计学意义(均P〉0.05),野生型组细胞凋亡率显著高于突变型组与两对照组(空白对照组为3.8%±0.5%,感染对照组为3.8%±0.4%,突变型组为3.2%±0.4%,野生型组为7.1%±0.7%)(均P〈0.05)。结论非p53依赖性通路中,野生型c-myc基因过表达能明显上调p14^ARF基因表达、诱导细胞凋亡,其促进增殖功能与诱导凋亡功能保持平衡,而突变后此作用丧失,致瘤性增加。 Objective To explore the regulation of p14^ARF expression and induction of cell apoptosis with the mutant and wild-type c-myc genes in a p53-independent pathway of signal transduction. Methods The mutant and wild-type c-myc genes were transfected by lentivirus into HCC1937 to form the stable overexpression cell lines. Uninfected cells and lentivirus-infected ones carrying no c-myc gene acted as blank and infection controls respectively. And c-myc and p14^ARF mRNA and protein, proliferation and apoptosis in HCC1937 with mutant and wild-type c-myc were detected by reverse transcription (RT)-PCR, Western blotting, thiazolyl blue tetrazolium bromide (MTT) and terminal deoxynucleotidyl transferase mediated XdUTP nick end labeling (TUNEL) respectively. Results After the lentivirus-mediated gene transfer, cmyc mRNA and protein expression increased in the mutant and wild-type groups, p14^ARF mRNA and protein increased in the wild-type group and the mutant group and there were significant difference between them with blank and infection controls (mutant groups:0. 560±0. 010,0. 154 ± 0. 011, wild-type groups :0. 651± 0. 010, 0. 382 ± 0. 013, both P 〈 0. 05 ). The group of mutant and wild-type c-myc could promote the proliferation of cell growth. And c-myc was more effective to induce apoptosis in the wild-type group as compared with the mutant group (7.1% ± 0. 7% vs 3.2% ± 0.4%, P 〈 0. 05 ). Conclusions In a p53independent pathway, the over-expression of wild-type c-myc obviously up-regulates the expression of p14^ARF. And cell apoptosis may be induced through the regulation of pl4^ARF-related gene, keep balance of proliferative promotion and apoptosis induction. When there is a loss-of-function of mutant c-myc, tumorigenicity increases via a disturbed balance of proliferative promotion and apoptosis induction.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第30期2140-2143,共4页 National Medical Journal of China
基金 山东省自然科学基金(Y2007C134)
关键词 基因 MYC 基因表达调控 细胞分裂 细胞凋亡 Genes,myc Gene expression regulation Cell division Apoptosis
  • 相关文献

参考文献11

  • 1Takayama N, Nishimura S, Nakamura S,et al. Transient activation of c-Myc expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Experimental Meal,2010, 207 : 2817-2830.
  • 2Benanti JA, Wang ML, Myers HE, et al. Epigenetic down- regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-myc. Mol Cancer Res, 2007, 5: 1181-1189.
  • 3Humbey O, Pimkina J ,Zilfpu J T,et al. The ARF tumor suppressor can promote the progressing of some tumors. Cancer Res,2008, 68:9608 -9613.
  • 4孟春晖,李福年,张佃良.c-myc基因慢病毒载体的构建及其意义[J].中华实验外科杂志,2011,28(4):543-546. 被引量:7
  • 5Bornkamm GW. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin Cancer Biol, 2009,19:351-365.
  • 6Thibodeaux CA, Liu XF, Disbmw GL, et al. hnmortalization and transformation of human mammary epithelial cells by a tumor- derived Myc mutant. Breast Cancer Res Treat, 2009, 116: 281-294.
  • 7De Filippis L, Ferrari D, Rota Nodari L,et al. Immortalization of human neural stem cells with the c-myc mutant T58A. PLoS One, 2008,3 : e3310.
  • 8Hemann MT, Bric A, Lowe SW,et al. Evasion of the p53 tumour surveillance network by tumour-derived Myc mutants. Nature, 2005,436:807-811.
  • 9Amente S, Gargano B, Diolaiti D,et al. p14AHF interacts with N- Myc anti inhibitits its transcriptional activity. FEBS Letters, 2007, 581:821-825.
  • 10Li ZL, Hann SR. The Myc-nucleophosmin-ARF network: a complex web unveiled. Cell Cycle,2009,8:2703-2707.

二级参考文献12

  • 1李跃萍,宋丽萍,邱曙东.慢病毒载体在肿瘤基因治疗中的应用[J].现代肿瘤医学,2006,14(12):1614-1617. 被引量:17
  • 2Hemann MT,Bric A,Lowe SW,et al. Evasion of the p53 tumour sur- veillance network by tumour-derived MYC mutants. Nature, 2005, 436:807-811.
  • 3Gazdar AF, Kumari V, Virmani A, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J Cancer,1998,78:766-774.
  • 4J.萨姆布鲁克,D.W.拉塞尔.分子克隆实验指南.第3版.北京科学出版社,2005:1282-1287.
  • 5Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res, 2000,462 : 31-47.
  • 6Egle A, Harris AW, Bouillet P, et al. Bim is a suppressor of Myc-in- duced mouse B Cell leukemia. Proc Nail Acad Sci USA,2004,101: 6164-6169.
  • 7Rob1 JM, Wang Z, Kasinathan P. Transgenic animal production and animal biotechnology. Theriogenology ,2007,67 : 127-133.
  • 8Ptashne M. A genetic switch:phage (Lambda) and higher organisms. Cambridge, MA : Cell Press, 1992,35:2345-2349.
  • 9Chen Q J, Zhou HM, Chen J, et al. A Gateway-based platform for mul- tigene plant transformation. Plant Mol Bio1,2006,62:927-936.
  • 10王志明,刘剑鸣,李萃,段朝军,黄云,李新营.人PPFP基因的重组慢病毒载体的构建和表达[J].中华实验外科杂志,2009,26(11):1435-1438. 被引量:6

共引文献6

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部